Search





Results 11-20 of 26.
 |   | 
JRC N°Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)
JRC701862012Bismuth-213 and Actinium-225 – Generator Performance and Evolving Therapeutic Applications of Two Generator-Derived Alpha-Emitting RadioisotopesMORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos
JRC709082012Measurement of the 225Ac half-lifePOMME Stefaan; MAROULI MARIA; SULIMAN GABRIEL; DIKMEN HASAN; VAN AMMEL Raf; JOBBAGY VIKTOR; DIRICAN A.; STROH HEIKO; PAEPEN Jan; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; MORGENSTERN Alfred
JRC701392012Orthotopic administration of 213Bi-Bevacizumab inhibits progression of PC3 xenografts in the prostateRIZVI S.m.a.; ALLEN B.j.; LEE C.s.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; CLARKE R.a.
JRC701822012DTPA complexation of bismuth in human blood serumMONTAVON Gilles; LE DU Alicia; CHAMPION J; RABUNG T.; MORGENSTERN Alfred
JRC702992012In vitro evaluation of alpha-particle emitter Ac-225 for somatostatin receptor radiotherapyGRAF Franziska; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; VENKATACHALAM S.; FOTTNER C.; WEBER M.m.; KAINA B; SCHRECKENBERGER M; MIEDERER Matthias
JRC729012012Synthesis of 213Bi-DOTATOC for peptide receptor alpha-therapy of GEP-NET patients refractory to beta therapyMORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; GIESEL Frederik; MIER Walter; HABERKORN Uwe; KRATOCHWIL Clemens
JRC702962012Radiopeptidtherapie des Ovarialkarzinoms mit Alphastrahlern: Verbesserte Tumorkontrolle durch Kombination von 213Bi-DTPA-F3 mit Taxol bei irreversiblen Zellzyklusarrest von Ovarialkarzinomzellen in der G2/M-PhaseSEIDL C.; VALLON M.; BLECHERT B.; GÄRTNER Florian; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.
JRC702982012Die intravesikale Radioimmuntherapie mit Bi-213-anti-EGFR Immunkonjugaten verursacht keine Schäden am UrothelMÜLLER Felix; SEIDL C.; WEIRICH G; RÖTZER S; FAZEL J; FRANK Annette; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SENEKOWITSCH-SCHMIDTKE R.
JRC648812012High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneumRAUCH C; SEIDL C.; SCHLAPSCHY M; SKERRA A; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SENEKOWITSCH-SCHMIDTKE R.
JRC658872012Polymersomes as nano-carriers to retain harmful recoil nuclides in alpha radionuclide therapy: a feasibility studyTHIJSEN L.; SCHAART D.r.; DE VRIES D.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DENKOVA A.g.